Expert panel offers solutions to improve recruitment for Alzheimer’s clinical trials
Clinical trials to inform new treatments for Alzheimer’s disease face more significant challenges in recruiting participants than most other disease areas. These trials also take longer to complete, cost more and often lack qualified participants from diverse backgrounds.
To tackle the … Read More »